BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Ressourcenzentrum Fur Genomforschung To Distribute GeneCopoeia's OmicsLink(TM) Human Full Length ORF Clones In Europe


10/19/2005 5:12:40 PM

GERMANTOWN, Md., Feb. 9 /PRNewswire/ -- GeneCopoeia, Inc. and Deutsches Ressourcenzentrum fur Genomforschung GmbH (RZPD) announced today that they entered into a partnership to distribute GeneCopoeia's seven sets of 16,000 human OmicsLink(TM) ORF expression clones in the region of EU Member States, and Norway, Switzerland, and Turkey. These seven sets of expression-ready clones contain full-length protein coding ORFs of human genes with various promoters, unique tags and other features that allow direct expression of proteins in E. coli, mammalian, yeast, insect cells and in vitro cell free translation systems. OmicsLink(TM) ORF expression clones also provide researchers with the capability of large-scale and high throughput analysis and understanding of the functions and behaviors of proteins for both in vivo and in vitro systems without doing any cloning work.

"This distribution partnership with RZPD provides us with the opportunity to strengthen our position in the Genomics and Proteomics research market in the EU member states," said Dr. Sun Lu, Executive Vice President of Business Development at GeneCopoeia, Inc. "RZPD is well known to be a premier provider of Genomics and Proteomcs tools and services including one of the most comprehensive collection of cDNA clones and the GenomeCube resource and knowledge database. OmicsLink(TM) ORF expression clones complement RZPD's portfolio very well. We fully expect that this distribution partnership will be beneficial to European users as well as to both organizations."

About RZPD:

RZPD is the largest service center for genome research in Europe. Based on the most comprehensive public clone collection worldwide, it provides high- quality research material, high throughput technology and automation solutions for academic institutions as well as for industrial applications. All material data available from RZPD is stored in a primary database and is cross-linked with records from other public sources.

About GeneCopoeia

Based in Maryland, USA -- a provider of high quality tools, innovative technologies and unique services for life sciences research. With world's largest collection of human ORF clones, including seven sets of OmicsLink(TM) expression clones and one set of Invitrogen Gateway(R) compatible shuttle clones, GeneCopoeia is in the unique position to provide solutions that can significantly accelerate Genomics and Proteomics research and development.

GeneCopoeia, Inc.

CONTACT: Dr. Martin Stock, Administrative Managing Director of RZPD,+49-30-32639-101, fax: +49-30-32639-111, m.stock@rzpd.de; or Dr. Sun Lu,Executive Vice President of GeneCopoeia, Inc., +1-301-515-6982, fax:+1-301-515-6083, slu@genecopoeia.com




 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES